220 related articles for article (PubMed ID: 29275924)
1. Pyridostigmine for the Reversal of Severe Adverse Reactions to Botulinum Toxin in Children.
Boerner RM; Young DL; Gnagi SH; White DR; Halstead LA
J Pediatr; 2018 Mar; 194():241-243. PubMed ID: 29275924
[TBL] [Abstract][Full Text] [Related]
2. Pyridostigmine for reversal of severe sequelae from botulinum toxin injection.
Young DL; Halstead LA
J Voice; 2014 Nov; 28(6):830-4. PubMed ID: 25008379
[TBL] [Abstract][Full Text] [Related]
3. Acute neuromuscular failure related to long-term botulinum toxin therapy.
Coletti Moja M; Dimanico U; Mongini T; Cavaciocchi V; Gerbino Promis PC; Grasso E
Eur Neurol; 2004; 51(3):181-3. PubMed ID: 15073447
[No Abstract] [Full Text] [Related]
4. Dysphagia as a complication of botulinum toxin injection to treat drooling.
Tighe D; Gok G; Moody A; Howlett D
Br J Oral Maxillofac Surg; 2014 Sep; 52(7):673; discussion 673-4. PubMed ID: 24845119
[No Abstract] [Full Text] [Related]
5. A case of dysphagia following botulinum toxin injection for neck rejuvenation.
Phothong W; Wanitphakdeedecha R; Keskool P; Manuskiatti W
J Cosmet Dermatol; 2017 Mar; 16(1):15-17. PubMed ID: 27637174
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Wallenberg's Syndrome related dysphagia with pyridostigmine.
Eker A; Kaymakamzade B; Akpinar S
Acta Neurol Belg; 2017 Mar; 117(1):329-331. PubMed ID: 27424039
[No Abstract] [Full Text] [Related]
7. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
[TBL] [Abstract][Full Text] [Related]
8. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
Fan KL; Wang YL; Chu G; Leung LP
J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
[TBL] [Abstract][Full Text] [Related]
9. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications.
Halleran DR; Lu PL; Ahmad H; Paradiso MM; Lehmkuhl H; Akers A; Hallagan A; Bali N; Vaz K; Yacob D; Di Lorenzo C; Levitt MA; Wood RJ
J Pediatr Surg; 2019 Nov; 54(11):2305-2310. PubMed ID: 31060739
[TBL] [Abstract][Full Text] [Related]
10. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
Chan KH; Liang C; Wilson P; Higgins D; Allen GC
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
[TBL] [Abstract][Full Text] [Related]
12. Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.
Iwase T; Iwase C
Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):415-6. PubMed ID: 16175373
[No Abstract] [Full Text] [Related]
13. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
[TBL] [Abstract][Full Text] [Related]
14. Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists.
Shariat-Madar B; Chun RH; Sulman CG; Conley SF
Otolaryngol Head Neck Surg; 2016 May; 154(5):924-7. PubMed ID: 26908558
[TBL] [Abstract][Full Text] [Related]
15. Mild to Moderate Dysphagia Following Very Low-dose Abobotulinumtoxin A for Platysmal Bands.
Obagi S; Golubets K
J Drugs Dermatol; 2017 Sep; 16(9):929-930. PubMed ID: 28915289
[TBL] [Abstract][Full Text] [Related]
16. Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.
Chiarello D; Piombo M; Corbetto M; Di Pino G; Assenza G; Capone F; Di Lazzaro V
Muscle Nerve; 2014 Sep; 50(3):456-7. PubMed ID: 24890202
[No Abstract] [Full Text] [Related]
17. Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis.
Witting N; Daugaard D; Prytz S; Biernat H; Diederichsen LP; Vissing J
J Neurol; 2022 Aug; 269(8):4154-4160. PubMed ID: 35244767
[TBL] [Abstract][Full Text] [Related]
18. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
Sheen-Ophir S; Almog Y
Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
[TBL] [Abstract][Full Text] [Related]
19. Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.
Dressler D
J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):604; author reply 604. PubMed ID: 12397170
[No Abstract] [Full Text] [Related]
20. Botulinum toxin A injection of UES in schizencephaly with dysphagia: Case report.
Nam KY; Kim C; Park JW; Lee HJ; Kwon BS
Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1935-7. PubMed ID: 26351064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
